Nyxoah S.A.

NASDAQ:NYXH

Medical - Instruments & Supplies

Healthcare
$0.86 +1.25%

+$0.02 today

Market cap
$87.45M
Beta
0.89
P/E (TTM)
-0.7
EPS (TTM)
-$1.99
52W Low $1.26High $8.59

Volume 0.09M

Average 0.22M

Income Statement

Follow revenue through to earnings.

Revenue

$10.02M

FY 2025 · Annual

+121.6% YoY

Operating Income

-$82.94M

FY 2025 · Annual

Net Income

-$90.08M

FY 2025 · Annual

Income Statement

EUR
Metric
FY 2021
Dec 2021
FY 2022
Dec 2022
FY 2023
Dec 2023
FY 2024
Dec 2024
FY 2025
Dec 2025
Revenue852K3.08M4.35M4.52M10.02M
Cost of Revenue303K1.15M1.66M1.55M3.69M
Gross Profit549K1.93M2.69M2.97M6.33M
Gross Margin64.4%62.7%61.9%65.7%63.1%
Research & Development5.95M15.86M27.66M34.33M42.82M
Selling, General & Admin11.11M18.86M20.65M28.46M46.44M
Operating Expenses26.79M34.43M47.79M61.78M89.27M
Depreciation & Amortization1.66M1.93M2.36M764K4.48M
EBITDA(22.59M)(27.89M)(42.08M)(53.77M)(82.9M)
EBITDA Margin-2651.5%-904.2%-967.8%-1189.2%-827.4%
Operating Income(26.24M)(32.5M)(45.1M)(58.81M)(82.94M)
Operating Margin-3080.0%-1053.8%-1037.3%-1300.8%-827.8%
Interest Income1K372K2.57M2.5M1.83M
Interest Expense386K237K1.21M1.9M1.69M
Other Income / Expenses1.6M2.44M445K2.38M(6.13M)
Income Before Tax(24.64M)(30.06M)(44.66M)(56.43M)(89.08M)
Pre-Tax Margin-2891.9%-974.6%-1027.1%-1248.2%-889.0%
Income Tax Expense2.98M1.17M(1.45M)2.8M1.01M
Net Income(27.62M)(31.23M)(43.21M)(59.24M)(90.09M)
Net Margin-3241.7%-1012.5%-993.8%-1310.2%-899.1%
EPS (Basic)(1.16)(1.21)(1.55)(1.81)(2.37)
EPS (Diluted)(1.16)(1.21)(1.55)(1.81)(2.37)
Weighted Avg Shares23.79M25.82M27.97M32.74M38.11M
Weighted Avg Shares (Diluted)23.79M25.82M27.97M32.74M38.11M

NYXH Earnings Waterfall · TTM

NASDAQ:NYXH · Revenue to Net Income

Key Ratios

EPS$-2.14
Gross Margin54.6%
Net Margin-850.1%
P/E Ratio-1.9
P/S Ratio73.6

Analysis

$16.3M of revenue converted into -$86.1M of net income for the selected period. Gross margin is 54.6% and net margin is -850.1%, showing how much revenue survives after costs and taxes. EPS is $-2.14, tying the income statement back to per-share earnings.

Recent Filings

Recent regulatory filings

FilingDescriptionDate
6-K6-K filingNov 5, 2026
6-K6-K filingOct 20, 2026
6-K6-K filingSep 29, 2026
6-K6-K filingSep 22, 2026
SC 13G/ASC 13G/A filingAug 14, 2026

How much revenue does NYXH generate?

Nyxoah S.A. (NYXH) reported $10.02M of revenue in fiscal 2025.

Is NYXH profitable?

Nyxoah S.A. (NYXH) reported -$90.08M of net income, with a net margin of -899.1%.